Immunostaining of ∆Np63 (using the p40 antibody) is equal to that of p63 and CK5/6 in high-grade ductal carcinoma in situ of the breast

Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype

(2014) Mieke Van Bockstal et al.   VIRCHOWS ARCHIV

Comparison of p40 (ΔNp63) and p63 expression in prostate tissues - which one is the superior diagnostic marker for basal cells?

(2013) Verena Sailer et al.   HISTOPATHOLOGY

Use of immunohistochemistry in the diagnosis of problematic breast lesions

(2013) Andrew H S Lee   JOURNAL OF CLINICAL PATHOLOGY

Progression from ductal carcinoma in situ to invasive breast cancer: Revisited

(2013) Catherine F. Cowell et al.   Molecular Oncology

DEGRO practical guidelines: radiotherapy of breast cancer II

(2013) R. Souchon et al.   STRAHLENTHERAPIE UND ONKOLOGIE

A Study of ΔNp63 Expression in Lung Non-Small Cell Carcinomas

(2012) Daisuke Nonaka   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Is DCIS Breast Cancer, and How Do I Treat it?

(2012) N. Bijker et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

The benefits and harms of breast cancer screening: an independent review

(2012)   LANCET